Advances in Intelligent Based Internet of Medical Things (IoMT) for COVID-19: Olfactory Disorders

Abstract

The accelerated spread of novel coronavirus has created humongous difficulties and challenges in the health care and response system. The entire globe does not want to leave any stone unturned to flatten the pandemic curve. Sensory loss has a strong association with COVID-19 infection, the respiratory disease caused by the novel coronavirus. If a person suffers from anosmia there is a high probability that the person has COVID-19 infection. Although fever is the most common and the first symptom of the infection, but loss of smell known as anosmia and fatigue are also very common initial symptoms of COVID-19 infection. Since COVID-19 infection is highly contagious, it is good to identify people with anosmia as the initial screening process to prevent the infection from spreading to the community as a whole. Technological innovations are growing up to save the affected people. According to statistics, the IoT healthcare market will reach $136.8 billion worldwide by 2021. Internet of Medical Things (IoMT) is the network of medical devices that strengthens machine to machine conversation. Internet of Medical things in association with Cloud and AI are highly helpful during this pandemic crisis. Thus this book chapter highlights the importance of IoMT with advanced technology to be used in medical field to fight against the COVID-19 virus and to flatten the pandemic curve.